| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06566807 | Oxygen Study-Orelabrutinib Combined With Obinutuzumab(O2) for First-Line Treatment of… | Marginal Zone Lymphoma | Recruiting |
| Not specified | |||
| NCT06328179 | Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene… | Acute Myeloid Leukemia | Recruiting |
| NCT06936488 | A Prospective, Single Arm, Open Label, Phase II Clinical Study on the Efficacy and Safety… | MSS/pMMR Type Metastatic Colorectal Adenocarcinoma Patients | Enrolling by Invitation |
| NCT07115550 | A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab… | Hepatocellular Carcinoma (HCC) | Not Yet Recruiting |